News Highlights: Top Company News of the Day
Scandinavian Airline SAS Files for Bankruptcy Protection
The carrier has filed for bankruptcy protection in the U.S.,
saying a move by about 1,000 of its pilots to go on strike would
worsen its already fraught finances.
CureVac Sues BioNTech Over mRNA and Covid Vaccines. Pfizer Stock Isn't Spared.
CureVac says its intellectual property portfolio protects
multiple inventions that are considered essential to Pfizer and
BioNTech's Covid-19 vaccine.
Blackstone Bets on Global Tourism Boom With Australian Resort Deal
As Covid-19 cases have fallen and international air travel has
increased, some resorts are benefiting.
Amazon, Microsoft, Google Strengthen Grip on Cloud
The three companies account for about two-thirds of cloud
spending and are using their size to maintain their hold on the
rapidly growing market.
China's Big Airbus Order Isn't an All-Clear for Airline Stocks
The big three Chinese carriers have just placed their first
significant order since the pandemic began. But all isn't well just
yet: There are still some obvious squalls brewing.
Sanctions Threaten Russia's Next Huge Oil Field
Vostok Oil, a vast patch in Russia's far north, faces setbacks
as Western sanctions impede its access to cash and technology.
New Zealand Treasury Bars The Wall Street Journal From Restricted Briefings Until 2025
New Zealand's Treasury will bar The Wall Street Journal from
attending restricted briefings for three years for publishing
budget information before the scheduled release time in May.
Smaller Companies Are Urged to Adopt Multifactor Authentication
Too many small and medium-size businesses rely on usernames and
passwords alone to secure their systems, leaving them vulnerable to
cyberattacks that could otherwise be prevented, government
officials and cybersecurity chiefs say.
Private-Equity Firms Poach Talent to Chase Wealthy Investors
Alternative-asset managers are furiously hiring investment
advisers and marketers as they seek to raise capital from
Little-Known Abortion Pill Maker Faces Scrutiny
The debate over medication abortions draws in the lone U.S.
manufacturer of brand-name mifepristone.
(END) Dow Jones Newswires
July 05, 2022 09:15 ET (13:15 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.